EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum vascular endothelial growth factor is a potential biomarker for acute mountain sickness

Nasenien Nourkami-Tutdibi, Jennifer Küllmer, Sven Dietrich, Dominik Monz, Michael Zemlin, Erol Tutdibi

Frontiers in Physiology · 30.03.2023 · 14

DOI: 10.3389/fphys.2023.1083808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Physiology, online erschienen am 30.03.2023. Verfasst von Nasenien Nourkami-Tutdibi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Saarland University Medical Center, Hospital for General Pediatrics and Neonatology, Homburg, Germany. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute mountain sickness (AMS) is the most common disease caused by hypobaric hypoxia (HH) in high-altitude (HA) associated with high mortality when progressing to high-altitude pulmonary edema (HAPE) and/or high-altitude cerebral edema (HACE). There is evidence for a role of pro- and anti-inflammatory cytokines in development of AMS, but biological pathways and molecular mechanisms underlying AMS remain elusive. We aimed to measure changes in blood cytokine levels and their possible association with the development of AMS.

Method

15 healthy mountaineers were included into this prospective clinical trial. All participants underwent baseline normoxic testing with venous EDTA blood sampling at the Bangor University in United Kingdom (69 m). The participants started from Beni at an altitude of 869 m and trekked same routes in four groups the Dhaulagiri circuit in the Nepali Himalaya. Trekking a 14-day route, the mountaineers reached the final HA of 5,050 m at the Hidden Valley Base Camp (HVBC). Venous EDTA blood sampling was performed after active ascent to HA the following morning after arrival at 5,050 m (HVBC). A panel of 21 cytokines, chemokines and growth factors were assessed using Luminex system (IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p40, IL-1ra, sIL-2Rα, IFN-γ, TNF-α, MCP-1, MIP-1α, MIP-1β, IP-10, G-CSF, GM-CSF, EGF, FGF-2, VEGF, and TGF-β1).

Results

There was a significant main effect for the gradual ascent from sea-level (SL) to HA on nearly all cytokines. Serum levels for TNF-α, sIL-2Rα, G-CSF, VEGF, EGF, TGF-β1, IL-8, MCP-1, MIP-1β, and IP-10 were significantly increased at HA compared to SL, whereas levels for IFN-γ and MIP-1α were significantly decreased. Serum VEGF was higher in AMS susceptible versus AMS resistant subjects ( p < 0.027, main effect of AMS) and increased after ascent to HA in both AMS groups ( p < 0.011, main effect of HA). Serum VEGF increased more from SL values in the AMS susceptible group than in the AMS resistant group ( p < 0.049, interaction effect).

Conclusion

Cytokine concentrations are significantly altered in HA. Within short interval after ascent, cytokine concentrations in HH normalize to values at SL. VEGF is significantly increased in mountaineers suffering from AMS, indicating its potential role as a biomarker for AMS.

Schlagwörter

Stichwörter der Autor:innen

acute mountain sicknessbiomarkercytokineshigh altitudehypobaric environmenthypobaric hypoxiainflammation

Autor:innen und Institutionen

  • Saarland University Medical Center, Hospital for General Pediatrics and Neonatology, Homburg, Germany.

Zitieren

APA

Nourkami-Tutdibi, N., Küllmer, J., Dietrich, S., Monz, D., Zemlin, M., & Tutdibi, E. (2023). Serum vascular endothelial growth factor is a potential biomarker for acute mountain sickness. Frontiers in Physiology, 14. https://doi.org/10.3389/fphys.2023.1083808

Vancouver

Nourkami-Tutdibi N, Küllmer J, Dietrich S, Monz D, Zemlin M, Tutdibi E. Serum vascular endothelial growth factor is a potential biomarker for acute mountain sickness. Frontiers in Physiology. 2023;14. doi:10.3389/fphys.2023.1083808

BibTeX
@article{NourkamiTutdibi2023,
  author = {Nourkami-Tutdibi, Nasenien and Küllmer, Jennifer and Dietrich, Sven and Monz, Dominik and Zemlin, Michael and Tutdibi, Erol},
  title = {Serum vascular endothelial growth factor is a potential biomarker for acute mountain sickness},
  journal = {Frontiers in Physiology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphys.2023.1083808}
}
Kostenlos starten →